ZA73939B - 3-acylhydrazonomethyl rifamycin sv - Google Patents

3-acylhydrazonomethyl rifamycin sv

Info

Publication number
ZA73939B
ZA73939B ZA730939A ZA73939A ZA73939B ZA 73939 B ZA73939 B ZA 73939B ZA 730939 A ZA730939 A ZA 730939A ZA 73939 A ZA73939 A ZA 73939A ZA 73939 B ZA73939 B ZA 73939B
Authority
ZA
South Africa
Prior art keywords
acylhydrazonomethyl
rifamycin
acylhydrazonomethyl rifamycin
Prior art date
Application number
ZA730939A
Other languages
English (en)
Inventor
R Cricchio
G Lancini
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of ZA73939B publication Critical patent/ZA73939B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA730939A 1972-03-27 1973-02-09 3-acylhydrazonomethyl rifamycin sv ZA73939B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2242172 1972-03-27

Publications (1)

Publication Number Publication Date
ZA73939B true ZA73939B (en) 1973-11-28

Family

ID=11196065

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA730939A ZA73939B (en) 1972-03-27 1973-02-09 3-acylhydrazonomethyl rifamycin sv

Country Status (24)

Country Link
US (1) US3865812A (fr)
JP (1) JPS5142120B2 (fr)
AR (3) AR205434A1 (fr)
AT (1) AT322106B (fr)
AU (1) AU467606B2 (fr)
BE (1) BE797344A (fr)
CA (1) CA999858A (fr)
CH (1) CH567511A5 (fr)
CS (1) CS168642B2 (fr)
DD (1) DD104517A5 (fr)
DE (1) DE2314478C3 (fr)
ES (1) ES413043A1 (fr)
FR (1) FR2182906B1 (fr)
GB (1) GB1388652A (fr)
HU (1) HU167316B (fr)
IE (1) IE37817B1 (fr)
IL (1) IL41532A0 (fr)
LU (1) LU67287A1 (fr)
NL (1) NL171360C (fr)
PL (1) PL89269B1 (fr)
RO (1) RO62882A (fr)
SE (1) SE381257B (fr)
SU (1) SU497777A3 (fr)
ZA (1) ZA73939B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1053787B (it) * 1974-10-29 1981-10-10 Pastori A Macrolidi azotati e loro preparazione
GB1478563A (en) * 1975-03-05 1977-07-06 Lepetit Spa Rifamycin derivatives
DE2728869A1 (de) * 1976-06-25 1977-12-29 Antibiotice Iasi Intreprindere Rifamycinen und verfahren zu deren herstellung
US4179439A (en) * 1977-07-01 1979-12-18 Intreprinderea De Antibiotice Iasi Rifamycins and method for their preparation
JPS6025436B2 (ja) * 1977-07-15 1985-06-18 イントレプリンデレア・デ・アンテイビオテイスイアシ 水溶性リフアマイシン
JPS5419997A (en) * 1977-07-15 1979-02-15 Intorepurinderea De Anteibiote 33formylrifamycin sv derivative
DE2918140C2 (de) * 1979-05-05 1985-02-07 Fresenius AG, 6380 Bad Homburg Dialysator
AU536524B2 (en) * 1979-06-28 1984-05-10 Gruppo Lepetit S.P.A. Water soluble hydrozones of 3-formylifamyan
US4447432A (en) * 1981-11-17 1984-05-08 Farmitalia Carlo Erba S.P.A. Azino rifamycins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH489520A (fr) * 1964-07-31 1970-04-30 Lepetit Spa Procédé de préparation d'un dérivé de la rifamycine SV
FR208F (fr) * 1964-07-31

Also Published As

Publication number Publication date
ES413043A1 (es) 1976-01-16
DD104517A5 (fr) 1974-03-12
AR199720A1 (es) 1974-09-23
GB1388652A (en) 1975-03-26
IL41532A0 (en) 1973-04-30
DE2314478C3 (de) 1981-01-08
CH567511A5 (fr) 1975-10-15
NL171360B (nl) 1982-10-18
FR2182906B1 (fr) 1975-10-31
SU497777A3 (ru) 1975-12-30
JPS5142120B2 (fr) 1976-11-13
AR203839A1 (es) 1975-10-31
RO62882A (fr) 1977-11-15
HU167316B (fr) 1975-09-27
JPS495998A (fr) 1974-01-19
CA999858A (en) 1976-11-16
FR2182906A1 (fr) 1973-12-14
AU467606B2 (en) 1975-12-04
AR205434A1 (es) 1976-05-07
ATA266074A (de) 1975-06-15
IE37817B1 (en) 1977-10-26
AU5342973A (en) 1974-09-19
CS168642B2 (fr) 1976-06-29
PL89269B1 (fr) 1976-11-30
NL7304085A (fr) 1973-10-01
SE381257B (sv) 1975-12-01
IE37817L (en) 1973-09-27
NL171360C (nl) 1983-03-16
US3865812A (en) 1975-02-11
DE2314478B2 (de) 1980-04-30
BE797344A (fr) 1973-07-16
AT322106B (de) 1975-05-12
LU67287A1 (fr) 1973-07-13
DE2314478A1 (de) 1973-10-04

Similar Documents

Publication Publication Date Title
CS609973A2 (en) Nosic informace
CS283873A2 (en) Zpusob rafinace tavenin zeleznych kovu
AU6329873A (en) Flameprofing
ZA73939B (en) 3-acylhydrazonomethyl rifamycin sv
AU5993373A (en) N-sulphenylated carbamidoximes
AU6362373A (en) N-propargylacetanilide herbicedes
GB1401579A (en) Indolo-quinolizines
GB1405757A (en) 7-amino-cephem compounds
ZA73302B (en) 3-hydrazonomethyl rifamycin sv
IL41276A0 (en) Dithiethane compounds
AU6332973A (en) Bulbholders
AU5191873A (en) Benzylpyrimidines
AU5711073A (en) Benzenesulfonyl-ureas benzenesulfonyl-ureas
AU5233473A (en) Nitro-imidazolyl-pyrimidines
AU5983773A (en) Alkylsulphonyl-2-trifluoromethyl-benzimidazoles
GB1400667A (en) 4-spirocyclopropyl-androstenes
AU5900173A (en) Thiazolopyrimidines
AU5340273A (en) Fixing means
MW6873A1 (en) Compounds
GB1400604A (en) 2-acyl-5-nitrothiazoles
AU6379973A (en) Goniolens
GB1368732A (en) Trans-polyalkenamers
AU6230173A (en) Pyralolo-pyrimidines
AU4956072A (en) Weatherboards
CA1010027A (en) 3-alkenyl substituted rifamycin sv compounds